Prescription drug · ANDA
diltiazem hydrochloride NDC 68382-597
Diltiazem hydrochloride 240 mg/1 · Capsule, Extended release · Oral · Zydus Pharmaceuticals (USA) Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68382-597-01 | 68382059701 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-597-01)Marketed from Sep 28, 2017 | |
| 68382-597-05 | 68382059705 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-597-05)Marketed from Oct 2, 2018 | |
| 68382-597-06 | 68382059706 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-597-06)Marketed from Sep 28, 2017 | |
| 68382-597-16 | 68382059716 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-597-16)Marketed from Sep 28, 2017 | |
| 68382-597-77 | 68382059777 | 10 BLISTER PACK in 1 CARTON (68382-597-77) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (68382-597-30)Marketed from Sep 28, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- diltiazem hydrochloride
- Generic name (nonproprietary)
- diltiazem hydrochloride
- Active ingredients
- Diltiazem hydrochloride — 240 mg/1
- Dosage form
- Capsule, Extended release
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 206534
- Marketing start
- Listing expires
- Other FDA classes
- Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)
- Identifiers
- Product ID 68382-597_3683dc39-602e-463a-b04a-6d066d2fe94dSPL ID 3683dc39-602e-463a-b04a-6d066d2fe94dSPL set ID 1e2f2025-0350-40c4-ab42-3b57f3d105a6RxCUI 830795, 830801, 830837, 830845, 830861UNII OLH94387TE
- Pharmacologic class
- Calcium Channel Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468382059701followed by a unit qualifier and the quantityPackage 68382-0597-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Diltiazem hydrochloride extended-release capsules are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive medications. Diltiazem hydrochloride extended-release capsules are indicated for the management of chronic stable angina and angina due to coronary artery spasm.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 206534
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| diltiazem hydrochloride | Diltiazem hydrochloride 300 mg/1 | Capsule, Extended releaseOral | Zydus Lifesciences Limited | 70771-1033 |
| diltiazem hydrochloride | Diltiazem hydrochloride 360 mg/1 | Capsule, Extended releaseOral | Zydus Lifesciences Limited | 70771-1034 |
| diltiazem hydrochloride | Diltiazem hydrochloride 240 mg/1 | Capsule, Extended releaseOral | Zydus Lifesciences Limited | 70771-1032 |
| diltiazem hydrochloride | Diltiazem hydrochloride 120 mg/1 | Capsule, Extended releaseOral | Zydus Lifesciences Limited | 70771-1030 |
| diltiazem hydrochloride | Diltiazem hydrochloride 180 mg/1 | Capsule, Extended releaseOral | Zydus Lifesciences Limited | 70771-1031 |
| diltiazem hydrochloride | Diltiazem hydrochloride 180 mg/1 | Capsule, Extended releaseOral | Zydus Pharmaceuticals (USA) Inc. | 68382-596 |
| diltiazem hydrochloride | Diltiazem hydrochloride 120 mg/1 | Capsule, Extended releaseOral | Zydus Pharmaceuticals (USA) Inc. | 68382-595 |
| diltiazem hydrochloride | Diltiazem hydrochloride 300 mg/1 | Capsule, Extended releaseOral | Zydus Pharmaceuticals (USA) Inc. | 68382-598 |
| diltiazem hydrochloride | Diltiazem hydrochloride 360 mg/1 | Capsule, Extended releaseOral | Zydus Pharmaceuticals (USA) Inc. | 68382-599 |
| diltiazem hydrochloride | Diltiazem hydrochloride 180 mg/1 | Capsule, Extended releaseOral | Bryant Ranch Prepack | 71335-9708 |